FDA Approved: SIGNIFOR — Supplemental Application (Recordati Rare Diseases, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Signifor (pasireotide) filed by Recordati Rare Diseases, Inc., potentially expanding its labeling/indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acromegaly
• Cushing Disease

Drugs mentioned

• SIGNIFOR (PASIREOTIDE)

Snippet

SUPPL AP for SIGNIFOR (PASIREOTIDE)